Showing results (551-560 of 3,716) with videos related to

Sort By:
Pageof 372
Investigational New Drugs|July 29, 2009
The induction of senescence-like growth arrest by protein kinase C-activating diterpene esters in solid tumor cellsSharon A Mason, Sarah-Jane Cozzi, Carly J Pierce, et al.
Investigational New Drugs|August 26, 2009
Involvement of non-protein thiols, mitochondrial dysfunction, reactive oxygen species and p53 in honey-induced apoptosisSaravana Kumar Jaganathan, Mahitosh Mandal
Investigational New Drugs|July 8, 2009
Phase I study of non-pegylated liposomal doxorubicin in combination with ifosfamide in adult patients with metastatic soft tissue sarcomasElisa Stroppa, Alexia Bertuzzi, Gabriele Di Comite, et al.
Investigational New Drugs|November 15, 2008
Protective role of Withaferin-A on immunoexpression of p53 and bcl-2 in 7,12-dimethylbenz(a)anthracene-induced experimental oral carcinogenesisKuppusamy Panjamurthy, Shanmugam Manoharan, Madhavan Ramados Nirmal, et al.
Investigational New Drugs|September 25, 2007
Prognostic factors among cancer patients with good performance status screened for phase I trialsNicolas Penel, Marie Vanseymortier, Marie-Edith Bonneterre, et al.
Investigational New Drugs|September 25, 2007
A phase II study of the heparanase inhibitor PI-88 in patients with advanced melanomaKarl D Lewis, William A Robinson, Michael J Millward, et al.
Investigational New Drugs|September 17, 2009
Salvage therapy with gemcitabine, ifosfamide, dexamethasone, and oxaliplatin (GIDOX) for B-cell non-Hodgkin's lymphoma: a consortium for improving survival of lymphoma (CISL) trialByeong-Bae Park, Won Seog Kim, Hyeon Seok Eom, et al.
Investigational New Drugs|September 17, 2009
Justification of the starting dose as the main determinant of accrual time in dose-seeking oncology phase 1 trialsNicolas Penel, Pierre Leblond, Amélie Lansiaux, et al.
Investigational New Drugs|September 17, 2009
Bevacizumab for salvage treatment of metastatic breast cancer: a systemic review and meta-analysis of randomized controlled trialsJae-Bok Lee, Ok Hee Woo, Kyong Hwa Park, et al.
Investigational New Drugs|September 17, 2009
Synthesis, characterization and in vitro anti-tumor activities of novel 9-ethyl-9H-purine derivativesRaghu Ningegowda, Amit Grover, Basappa, et al.
Pageof 372